{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:04:05Z","timestamp":1789596245549,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.arr.2026.103173","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:07:24Z","timestamp":1778591244000},"page":"103173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Plasma p-Tau217 and A\u03b242\/40 for identifying amyloid PET positivity in cognitively unimpaired asian individuals: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0662-5637","authenticated-orcid":false,"given":"Itsuki","family":"Terao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wakako","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2026.103173_bib1","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1002\/alz.13687","article-title":"Fully automated measurement of plasma A\u03b242\/40 and p-tau181: analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts","volume":"20","author":"Bellomo","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2026.103173_bib2","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1001\/jamaneurol.2023.3599","article-title":"APOE genotype and Alzheimer disease risk across age, sex, and population ancestry","volume":"80","author":"Belloy","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2026.103173_bib3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/jnnp-2021-327864","article-title":"Plasma A\u03b2 as a biomarker for predicting A\u03b2-PET status in Alzheimer's disease\uff1aa systematic review with meta-analysis","volume":"93","author":"Cheng","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2026.103173_bib4","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1007\/s00415-023-11626-0","article-title":"The association of subjective sleep characteristics and plasma biomarkers of Alzheimer's disease pathology in older cognitively unimpaired adults with higher amyloid-\u03b2 burden","volume":"270","author":"Chu","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2026.103173_bib5","unstructured":"R. Core Team, 2023. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing."},{"key":"10.1016\/j.arr.2026.103173_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70469","article-title":"Comparison of plasma p-tau217\/A\u03b242, p-tau217, and A\u03b242\/A\u03b240 biomarkers by race to detect Alzheimer's disease","volume":"21","author":"Cousins","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2026.103173_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011458","article-title":"Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS)","volume":"6","author":"Downes","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.arr.2026.103173_bib8","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/jamaneurol.2024.3770","article-title":"Alzheimer disease as a clinical-biological construct-an international working group recommendation","volume":"81","author":"Dubois","year":"2024","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2026.103173_bib9","unstructured":"Higgins, J., Thomas, J., Chandler, J., Cumpston, M., Li, T., Pag, M., Welch, V., 2022. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane."},{"key":"10.1016\/j.arr.2026.103173_bib10","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1001\/jamaneurol.2025.0778","article-title":"IWG and AA criteria\u2014where the differences matter","volume":"82","author":"Jack","year":"2025","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2026.103173_bib11","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's association workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2026.103173_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70765","article-title":"Body mass index and blood volume influence plasma biomarkers and positron emission tomography classification in preclinical Alzheimer's disease","volume":"21","author":"Jacobs","year":"2025","journal-title":"Alzheimer's. & Dement."},{"key":"10.1016\/j.arr.2026.103173_bib13","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.1002\/alz.14247","article-title":"Ethnic differences in the prevalence of amyloid positivity and cognitive trajectories","volume":"20","author":"Jang","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2026.103173_bib14","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis","volume":"313","author":"Jansen","year":"2015","journal-title":"Jama"},{"key":"10.1016\/j.arr.2026.103173_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2183\/pjab.90.353","article-title":"Novel plasma biomarker surrogating cerebral amyloid deposition","volume":"90","author":"Kaneko","year":"2014","journal-title":"Proc. Jpn Acad. Ser. B Phys. Biol. Sci."},{"key":"10.1016\/j.arr.2026.103173_bib16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13195-025-01826-3","article-title":"Plasma phosphorylated tau 217 and amyloid\u2011\u03b2 42\/40 for amyloid risk in subgroups","volume":"17","author":"Kang","year":"2025","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.arr.2026.103173_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14458","article-title":"Diagnostic accuracy of phosphorylated tau217 in detecting Alzheimer's disease pathology among cognitively impaired and unimpaired: a systematic review and meta-analysis","volume":"21","author":"Khalafi","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2026.103173_bib18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13195-025-01778-8","article-title":"Plasma biomarkers for early detection of alzheimer's disease: a cross-sectional study in a Japanese cohort","volume":"17","author":"Kubota","year":"2025","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.arr.2026.103173_bib19","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/s43587-025-00904-3","article-title":"Comprehensive evaluation of plasma tau biomarkers for detecting and monitoring Alzheimer\u2019s disease in a multicenter and multiethnic aging population","volume":"5","author":"Lan","year":"2025","journal-title":"Nat. Aging"},{"key":"10.1016\/j.arr.2026.103173_bib20","article-title":"Blood-based biomarkers for Alzheimer's disease","volume":"14","author":"Leuzy","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.arr.2026.103173_bib21","doi-asserted-by":"crossref","first-page":"e1681","DOI":"10.1212\/WNL.0000000000012727","article-title":"Comparing the clinical utility and diagnostic performance of CSF P-Tau181, P-Tau217, and P-Tau231 assays","volume":"97","author":"Leuzy","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2026.103173_bib22","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3233\/JAD-160722","article-title":"Cerebrospinal fluid A\u03b242\/40 corresponds better than A\u03b242 to Amyloid PET in Alzheimer's disease","volume":"55","author":"Lewczuk","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2026.103173_bib23","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","article-title":"Dementia prevention, intervention, and care: 2024 report of the <em>Lancet<\/em> standing commission","volume":"404","author":"Livingston","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2026.103173_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/jamaneurol.2025.4721","article-title":"Plasma phosphorylated Tau 217 and amyloid burden in older adults without cognitive impairment: a meta-analysis","volume":"83","author":"Malek-Ahmadi","year":"2026","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2026.103173_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz2387","article-title":"A\u03b2 deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer\u2019s disease","volume":"6","author":"Mattsson-Carlgren","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.arr.2026.103173_bib26","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1007\/s00415-023-12148-5","article-title":"Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort","volume":"271","author":"Mendes","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2026.103173_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13195-024-01469-w","article-title":"Combining plasma A\u03b2 and p-tau217 improves detection of brain amyloid in non-demented elderly","volume":"16","author":"Niimi","year":"2024","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.arr.2026.103173_bib28","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"10.1016\/j.arr.2026.103173_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70828","article-title":"Blood-based biomarkers for detecting Alzheimer's disease pathology in cognitively impaired individuals within specialized care settings: a systematic review and meta-analysis","volume":"21","author":"Pahlke","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2026.103173_bib30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neurobiolaging.2023.06.013","article-title":"Sex and APOE genotype differences in amyloid deposition and cognitive performance along the Alzheimer's continuum","volume":"130","author":"Pan","year":"2023","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2026.103173_bib31","article-title":"Estimating the time course of biomarker changes in Alzheimer's disease","author":"Raket","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103173_bib32","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/nrneurol.2014.181","article-title":"Classifying neurocognitive disorders: the DSM-5 approach","volume":"10","author":"Sachdev","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2026.103173_bib33","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41582-024-00977-5","article-title":"Acceptable performance of blood biomarker tests of amyloid pathology \u2014 recommendations from the Global CEO Initiative on Alzheimer\u2019s disease","volume":"20","author":"Schindler","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2026.103173_bib34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13195-022-00977-x","article-title":"Combination of gut microbiota and plasma amyloid-\u03b2 as a potential index for identifying preclinical Alzheimer's disease: a cross-sectional analysis from the SILCODE study","volume":"14","author":"Sheng","year":"2022","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.arr.2026.103173_bib35","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jamaneurol.2022.4485","article-title":"Association of phosphorylated tau biomarkers with amyloid positron emission tomography vs tau positron emission tomography","volume":"80","author":"Therriault","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2026.103173_bib36","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s43587-024-00731-y","article-title":"Diagnosis of Alzheimer\u2019s disease using plasma biomarkers adjusted to clinical probability","volume":"4","author":"Therriault","year":"2024","journal-title":"Nat. Aging"},{"key":"10.1016\/j.arr.2026.103173_bib37","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S1474-4422(25)00227-3","article-title":"Blood phosphorylated tau for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"24","author":"Therriault","year":"2025","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2026.103173_bib38","series-title":"US Food and Drug Administration","article-title":"Elecsys \u03b2-amyloid (1-42) CSF II, Elecsys phospho-tau (181P) CSF: 510(k) substantial equivalence determination decision summary","author":"U. S. Food Drug Administration","year":"2022"},{"key":"10.1016\/j.arr.2026.103173_bib39","series-title":"US Food and Drug Administration","article-title":"Elecsys \u03b2-amyloid (1-42) CSF II, elecsys total-tau CSF substantial equivalence determination decision summary","author":"U. S. Food Drug Administration","year":"2023"},{"key":"10.1016\/j.arr.2026.103173_bib40","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3389\/fnagi.2025.1660755","article-title":"Validation of the robustness of blood-based biomarkers for predicting amyloid-\u03b2 positivity in Chinese populations","volume":"17","author":"Wang","year":"2025","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2026.103173_bib41","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.arr.2026.103173_bib42","unstructured":"World Health Organization, 2024. Preferred product characteristics of blood-based biomarker diagnostics for Alzheimer disease. World Health Organization, Geneva."},{"key":"10.1016\/j.arr.2026.103173_bib43","article-title":"Plasma p-tau217, p-tau181, and NfL as early indicators of dementia risk in a community cohort: the Shanghai aging study","volume":"15","author":"Xiao","year":"2023","journal-title":"Alzheimers Dement (Amst."},{"key":"10.1016\/j.arr.2026.103173_bib44","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/jamaneurol.2025.5530","article-title":"Plasma phosphorylated Tau 217 cutoffs for amyloid pathology and kidney function, body mass index, and anemia","volume":"83","author":"Yun","year":"2026","journal-title":"JAMA Neurol."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726001650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726001650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:47:29Z","timestamp":1780516049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163726001650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":44,"alternative-id":["S1568163726001650"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2026.103173","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma p-Tau217 and A\u03b242\/40 for identifying amyloid PET positivity in cognitively unimpaired asian individuals: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2026.103173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103173"}}